MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manchanda, T.
Right arrow Articles by Rieder, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manchanda, T.
Right arrow Articles by Rieder, M. J.

Vol. 62, Issue 5, 1011-1026, November 2002

Haptenation of Sulfonamide Reactive Metabolites to Cellular Proteins

Tarang Manchanda, David Hess, Lianna Dale, Stephen G. Ferguson, and Michael J. Rieder

Section of Paediatric Clinical Pharmacology, Toxicology & Experimental Therapeutics, Departments of Paediatrics, Pharmacology & Toxicology, and Medicine, Faculty of Medicine & Dentistry, University of Western Ontario, Ontario, Canada (T.M., D.H., M.J.R.); and Child Health Research Institute - Robarts Research Institute Children's Hospital of Western Ontario London, Ontario, Canada (L.D., S.G.F., M.J.R.)

Adverse drug reactions are a major problem complicating medical therapy. The pathogenesis of many severe adverse drug reactions, notably hypersensitivity reactions, is poorly understood. The sulfonamides are associated with severe hypersensitivity reactions. The initial pathogenesis seems to be caused by bioactivation of the parent drug to a reactive intermediate and subsequent propagation by the immune system. The determinants of the immune response are not known. We explored the formation of sulfonamide haptens in Molt-3 and HEPA 1C1C7 cells after incubation with sulfamethoxazole (SMX), the hydroxylamine of sulfamethoxazole (SMX-HA), or the nitroso of sulfamethoxazole (SMX-NO). Haptenation was demonstrated with SMX-HA and SMX-NO but not SMX; this occurred at concentrations below that associated with toxicity (significant haptenation was seen at 25 to 50 µM). Thus, haptenation occurred presumably onto viable cells. Haptenation occurred rapidly; haptenation of cell surface proteins was demonstrated within 5 min. This did not occur indiscriminately; confocal microscopy demonstrated haptenation onto specific sites on the cell membrane. We found that haptenation was significantly inhibited by thiols and other antioxidants (p < 0.05). Sulfonamide-specific haptens were rapidly internalized by what seemed to be a caveolae-dependent process. It seems that sulfonamide reactive metabolites haptenated specific cell surface proteins that are rapidly internalized. Understanding the specific protein target(s) for haptenation and how these haptens are processed will be important in understanding the immune mediation of sulfonamide hypersensitivity adverse drug reactions.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
L. Cheng, B. J. Stewart, Q. You, D. R. Petersen, J. A. Ware, J. R. Piccotti, T. T. Kawabata, and C. Ju
Covalent Binding of the Nitroso Metabolite of Sulfamethoxazole Is Important in Induction of Drug-Specific T-Cell Responses in Vivo
Mol. Pharmacol., June 1, 2008; 73(6): 1769 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. P. Sanderson, D. J. Naisbitt, J. Farrell, C. A. Ashby, M. J. Tucker, M. J. Rieder, M. Pirmohamed, S. E. Clarke, and B. K. Park
Sulfamethoxazole and Its Metabolite Nitroso Sulfamethoxazole Stimulate Dendritic Cell Costimulatory Signaling
J. Immunol., May 1, 2007; 178(9): 5533 - 5542.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Roychowdhury, P. M. Vyas, and C. K. Svensson
Formation and Uptake of Arylhydroxylamine-Haptenated Proteins in Human Dendritic Cells
Drug Metab. Dispos., April 1, 2007; 35(4): 676 - 681.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. Lin, M J. Tucker, and M. J Rieder
Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection
Ann. Pharmacother., September 1, 2006; 40(9): 1594 - 1601.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
P. M. Vyas, S. Roychowdhury, and C. K. Svensson
ROLE OF HUMAN CYCLOOXYGENASE-2 IN THE BIOACTIVATION OF DAPSONE AND SULFAMETHOXAZOLE
Drug Metab. Dispos., January 1, 2006; 34(1): 16 - 18.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Roychowdhury, P. M. Vyas, T. P. Reilly, A. A. Gaspari, and C. K. Svensson
Characterization of the Formation and Localization of Sulfamethoxazole and Dapsone-Associated Drug-Protein Adducts in Human Epidermal Keratinocytes
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 43 - 52.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Farrell, D. J. Naisbitt, N. S. Drummond, J. P. H. Depta, F. J. Vilar, M. Pirmohamed, and B. K. Park
Characterization of Sulfamethoxazole and Sulfamethoxazole Metabolite-Specific T-Cell Responses in Animals and Humans
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 229 - 237.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics